Series D startup

Who invested in Shanghai Cell Therapy Group

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$77Mraised across 1 round since 2021, from 1 source

Latest round
Series D, $77MMar 2021
Investors
1
See who backed them

The rounds

  1. Mar 2021
    Series D$77M

    Source recorded

Everyone who backed them

Legend CapitalVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Shanghai Cell Therapy Group

Who invested in Shanghai Cell Therapy Group?

Shanghai Cell Therapy Group's investors include Legend Capital.

How much has Shanghai Cell Therapy Group raised?

Shanghai Cell Therapy Group has raised $77M across 1 round since 2021.

When did Shanghai Cell Therapy Group last raise?

Shanghai Cell Therapy Group's most recent round was a Series D of $77M in Mar 2021.

What was Shanghai Cell Therapy Group's biggest round?

Its most recent round, $77M in Mar 2021, is also its largest on record.

Who backed Shanghai Cell Therapy Group first?

Shanghai Cell Therapy Group's first round on record, in Mar 2021, was backed by Legend Capital.

What stage is Shanghai Cell Therapy Group at?

Shanghai Cell Therapy Group's latest named round is a Series D, in Mar 2021.

Companies like Shanghai Cell Therapy Group

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.